Ten patients who received Arexvy and four patients who received placebo experienced atrial fibrillation within 30 days of vaccination. The company is planning to assess risk for atrial fibrillation in postmarking studies, the FDA said. The European Medicine Agency’s Committee for Medicinal Products ...
With U.S. vaccination rates falling, "I encourage older adults to follow CDC guidance and get vaccinated for RSV as we enter this year’s and every year’s respiratory disease season," said study co-authorDr. Shaun Grannis. Grannis is vice president for data and analy...
“It accomplishes what vaccination does, but instead of the child’s immune system having to do that, you’re just giving them the antibodies,” William Petri, MD, PhD, professor of immunology and infectious disease at the University of Virginia School of Medicine, tells SELF. Some babies ...
Pfizer told the FDA committee Thursday that maternal vaccination could prevent up to 16,000 hospitalizations and more than 300,000 visits to the doctor due to RSV among this age group each year if the vaccine is universally applied. However, the vaccine does not offer protection throughout the...
An estimated 3,000 to 6,000 people develop Guillain-Barre syndrome in the U.S. each year—either after being infected by a virus or linked to a vaccination—and it's more common in older people, according to the CDC. Most people fully recover, but some have permanent nerve damage. ...
This group, together with adults over 65 with underlying cardiovascular or pulmonary conditions, could be key target populations for RSV vaccination. Summary The medical community often underestimates the burden of Respiratory Syncytial Virus (RSV) in older adults, overshadowed by the prominence of ...
“Those who recall the stress that the tripledemic placed on the nation’s hospitals last fall will understand why older individuals and those who are pregnant should discuss the advisability of RSV vaccination with their health care providers,” said Kathleen Hall Jamieson, PhD, director of ...
A 78-year-old woman in Japan was diagnosed with Guillain-Barre syndrome nine days after receiving GSK's vaccine. She was discharged from the hospital six months after vaccination. The woman was the only case of Guillain-Barre syndrome out 15,000 people who received the shot....
If the CDC ultimately recommends the vaccination for some or even all seniors, it will add another shot for the fall along with their yearly flu vaccine – and maybe another COVID-19 booster. “We’ll have to educate the population that this virus that not everyone has heard about is ac...
After challenge with RSV, viral loads in the lungs of immunized mice were reduced by 2–3 logs with no signs of an enhanced disease induced by the vaccination. Even a single intranasal immunization significantly reduced viral load by a factor of more than 100-fold. RSV neutralizing antibodies ...